Comparative efficacy of commercial infectious bursal disease vaccination strategies against emerging novel variant IBDV (Genotype A2d)

Comparative Immunology, Microbiology and Infectious Diseases · Published 2026-07-13 · DOI 10.1016/j.cimid.2026.102501

Authors (11)

Kamal Samy Ahmed Mohamed Issa, Hany Fawzy Ellakany, Ahmed Ramadan Gado, Shady Hesham Elrayes, Ismail Ismail Abughanima, Ahmed R. Elbestawy, Rania F. El Naggar, Ahmed H. Salaheldin, Mohammed A. Abdelsabour, Hatem S. Abd El-Hamid, Mohammed A. Rohaim

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Issa, K., Ellakany, H., Gado, A., et al. (2026). Comparative efficacy of commercial infectious bursal disease vaccination strategies against emerging novel variant IBDV (Genotype A2d). Comparative Immunology, Microbiology and Infectious Diseases. https://doi.org/10.1016/j.cimid.2026.102501

Related articles